Vericel Corporation - Common Stock (VCEL)
Frequently Asked Questions About Vericel Corporation - Common Stock (VCEL)
How does Vericel approach patient access to its therapies?
Vericel is dedicated to improving patient access to its therapies through patient assistance programs, collaborations with healthcare providers, and educational initiatives aimed at informing healthcare professionals about its products.
How does Vericel conduct research and development?
Vericel conducts research and development through a combination of in-house capabilities and collaborations with academic institutions and other research organizations. This strategy allows them to remain at the forefront of regenerative medicine innovations.
How does Vericel ensure product quality and safety?
Vericel ensures product quality and safety through rigorous quality control processes, compliance with Good Manufacturing Practices (GMP), and ongoing monitoring and evaluation as mandated by regulatory authorities such as the FDA.
How does Vericel's MACI product work?
MACI is an advanced therapy that involves harvesting a small piece of the patient's cartilage, which is then expanded and cultured to create a matrix of chondrocytes. This matrix is surgically implanted into the defect in the knee to support cartilage regeneration and repair.
Is Vericel publicly traded?
Yes, Vericel Corporation is publicly traded on the NASDAQ under the ticker symbol VCEL. This allows investors to buy and sell shares of the company on the stock market.
What are some of Vericel's key products?
Vericel's key products include MACI (Matrix Autologous Chondrocyte Implantation) for treating cartilage defects in the knee, and Epicel, a cultured epidermal autograft for patients with severe burns. These products represent significant advancements in the treatment of their respective conditions.
What are the main therapeutic areas Vericel focuses on?
Vericel primarily focuses on orthopedic and dermatological therapies. Its products are designed to address conditions such as cartilage defects in joints and extensive skin injuries due to burns or chronic wounds.
What does Vericel Corporation do?
Vericel Corporation is a biotechnology company that specializes in advanced cell therapies and regenerative medicine. It focuses on developing and commercializing innovative therapies for patients with unmet medical needs, particularly in the fields of orthopedics and dermatology.
What future prospects does Vericel see?
Vericel anticipates continued growth fueled by expanding its product portfolio, leveraging advances in regenerative medicine, and exploring new markets. The company is committed to addressing significant unmet medical needs in the patient populations it serves.
What is Epicel and its uses?
Epicel is a cellular product used for the treatment of patients with deep partial-thickness and full-thickness burns. It is derived from the patient’s own skin cells, allowing for the growth of new skin that can help in healing and restoring skin integrity.
What is the business model of Vericel?
Vericel's business model centers around the development, manufacturing, and commercialization of advanced cell therapies. The company generates revenue primarily through the sale of its products and is focused on expanding its market presence and product offerings.
What is Vericel’s impact on patient care?
Vericel's products have a significant impact on patient care by providing new treatment options for patients with challenging conditions, improving recovery times, and potentially reducing the need for more invasive surgical procedures.
What is Vericel’s mission statement?
Vericel's mission is to deliver innovative cell-based therapies that improve the quality of life for patients with serious diseases and injuries. The company is committed to advancing the field of regenerative medicine through research and clinical development.
What recent developments has Vericel announced?
Vericel regularly announces updates regarding clinical trials, product launches, and partnerships. To stay informed about recent developments, it is best to follow their press releases and investor relations updates.
What regulatory approvals has Vericel received?
Vericel has obtained regulatory approvals from the U.S. Food and Drug Administration (FDA) for its key products, including MACI and Epicel. These approvals validate the safety and efficacy of their therapies for public use.
What types of clinical trials does Vericel conduct?
Vericel conducts a range of clinical trials, including Phase I, II, and III studies focused on evaluating the safety and efficacy of its cell-based therapies. These trials are essential for obtaining regulatory approvals and ensuring the best outcomes for patients.
When was Vericel Corporation founded?
Vericel Corporation was founded in 1981 and has since evolved from its origins in cell therapy to focus on developing and commercializing innovative regenerative medicine products that improve patient outcomes.
Where is Vericel Corporation headquartered?
Vericel Corporation is headquartered in Ann Arbor, Michigan, where it conducts research, development, and commercial operations related to its innovative therapies.
Who are the key leaders at Vericel Corporation?
Vericel is led by a team of experienced executives with backgrounds in biotechnology, medicine, and business. Their leadership is pivotal in driving the company’s strategic vision, operations, and product development initiatives.
Who are Vericel's competitors?
Vericel competes with other companies in the regenerative medicine sector, including companies focused on cell therapy, tissue engineering, and biologics for orthopedic and dermatologic applications.
What is the current price of Vericel Corporation - Common Stock?
The current price of Vericel Corporation - Common Stock is 42.63
When was Vericel Corporation - Common Stock last traded?
The last trade of Vericel Corporation - Common Stock was at 2:13 pm EDT on April 4th, 2025
What is the market capitalization of Vericel Corporation - Common Stock?
The market capitalization of Vericel Corporation - Common Stock is 1.99B
How many shares of Vericel Corporation - Common Stock are outstanding?
Vericel Corporation - Common Stock has 46.63M shares outstanding.